On Wednesday the 7th October the High Court ruled that the breast cancer gene BRCA-1 could not be patented.
Myriad Genetics, the company behind the discovery came out after this decsion expressing concerns that it would result in Australia being out of step with its trading partners.
Aroha spoke with leading medical lawyer for Slater and Gordon, Bill Madden about the case, the High Court ruling, and what will happen next.
Featured in story;
Bill Madden - Slater and Gordon Medical Lawyer
Story by;
Aroha Liebhart